Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,886
Closed -$528K 258
2025
Q1
$528K Buy
5,886
+985
+20% +$92K 0.1% 153
2024
Q4
$488K Buy
4,901
+1,524
+45% +$157K 0.09% 141
2024
Q3
$384K Buy
3,377
+46
+1% +$5.46K 0.08% 152
2024
Q2
$412K Buy
+3,331
New +$429K 0.09% 127
2022
Q3
Sell
-3,068
Closed -$280K 150
2022
Q2
$280K Sell
3,068
-193
-6% -$17.1K 0.1% 127
2022
Q1
$268K Sell
3,261
-140
-4% -$11K 0.1% 134
2021
Q4
$261K Sell
3,401
-522
-13% -$41.6K 0.1% 147
2021
Q3
$295K Sell
3,923
-170
-4% -$12.9K 0.13% 125
2021
Q2
$319K Buy
+4,093
New +$304K 0.19% 99

Other funds holding MRK

Fermata Advisors's MRK Position: Q2 2025 in Review

Fermata Advisors sold out of Merck (MRK) in Q2 2025, closing a stake of 5,886 shares — an estimated $528K sold.

Fermata Advisors first reported a position in MRK in Q2 2021 and held it in 9 quarters. The position peaked at $528K in Q1 2025. 3,327 funds tracked by Wall St. Rank hold MRK as of Q2 2025.

  • Fermata Advisors reported no remaining Merck position as of Q2 2025 after selling out during the quarter.
  • Fermata Advisors sold 5,886 Merck shares in Q2 2025, an estimated $528K.
  • Fermata Advisors first reported a position in Merck in Q2 2021 and held it in 9 quarters.
  • Fermata Advisors's Merck position peaked at $528K in Q1 2025.
  • 3,327 funds tracked by Wall St. Rank held Merck as of Q2 2025.

Based on Fermata Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.